PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)

Authors :: N Ruperto
K. Minden
J Wang
Karen Onel
Rubén Burgos-Vargas
F De Benedetti
A Martini
Kamal N. Bharucha
Eileen Baildam
Barry L. Myones
Hans Iko Huppertz
Daniel J. Lovell
Hermine I. Brunner
G. Horneff
Source :: Pediatric Rheumatology Online Journal
Publication Year :: 2013
Publisher :: Springer Science and Business Media LLC, 2013.
Abstract: In the phase 3 TENDER trial of TCZ in patients with sJIA, decreases in neutrophil count were commonly observed.

Full Text Access

Tools